Column Group LLC

← Tracker

Institutional

CIK 0001833486

$100.7M

Reported AUM

Positions

Q1 2026

Period

2026-05-18

Filed

The Brief · Column Group LLC · Q1 2026

AI · grounded in 13F

Column Group LLC closed its position in Tenaya Therapeutics, Inc. TNYA, reducing its holdings by $6.69M. The fund also exited its position in RAPT Therapeutics Inc, resulting in a $5.29M decrease. Conversely, the fund accumulated shares of Surrozen, Inc., increasing its position by 3.54%.

Portfolio · Q1 2026

Top holdings

QoQ vs Q4 2025

#	Ticker	Issuer	Value	% of book	Δ shares (QoQ)	Status
1	—	Surrozen, Inc.	$55.8M	55.45%	+65,600	+3.5%
2	ORIC	ORIC Pharmaceuticals Inc.	$44.9M	44.55%	—	HELD
3	RVMD	Revolution Medicines Inc	$4K	0.00%	—	HELD
4	TNYA	Tenaya Therapeutics, Inc.	—	—	-9,400,290	EXITED
5	—	RAPT Therapeutics Inc	—	—	-156,270	EXITED

Source: SEC EDGAR · accession 0001193125-26-227853. 13F discloses long positions only — shorts, foreign equities, and options are excluded.